CA2327188A1 - Composes calcilytiques et leur utilisation - Google Patents
Composes calcilytiques et leur utilisation Download PDFInfo
- Publication number
- CA2327188A1 CA2327188A1 CA002327188A CA2327188A CA2327188A1 CA 2327188 A1 CA2327188 A1 CA 2327188A1 CA 002327188 A CA002327188 A CA 002327188A CA 2327188 A CA2327188 A CA 2327188A CA 2327188 A1 CA2327188 A1 CA 2327188A1
- Authority
- CA
- Canada
- Prior art keywords
- group
- alkyl
- chloro
- hydroxy
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
Abstract
La présente invention concerne des composés et des compositions calcilytiques d'un type nouveau ainsi que leur utilisation pour le traitement de l'homéostasie minérale et osseuse anormale.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8108798P | 1998-04-08 | 1998-04-08 | |
US60/081,087 | 1998-04-08 | ||
PCT/US1999/007760 WO1999051241A1 (fr) | 1998-04-08 | 1999-04-08 | Composes calcilytiques et leur utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2327188A1 true CA2327188A1 (fr) | 1999-10-14 |
Family
ID=22162024
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002327188A Abandoned CA2327188A1 (fr) | 1998-04-08 | 1999-04-08 | Composes calcilytiques et leur utilisation |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1069901A4 (fr) |
JP (1) | JP2002510636A (fr) |
AR (1) | AR014975A1 (fr) |
AU (1) | AU3551399A (fr) |
CA (1) | CA2327188A1 (fr) |
CO (1) | CO5021223A1 (fr) |
WO (1) | WO1999051241A1 (fr) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ECSP003590A (es) * | 1999-07-31 | 2002-02-25 | Smithkline Beecham Corp | Compuestos calcioliticos |
AR030684A1 (es) * | 2000-01-24 | 2003-09-03 | Smithkline Beecham Corp | Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos |
US20030018203A1 (en) | 2002-07-17 | 2003-01-23 | Largo Maria Amparo | Calcilytic compounds |
CZ2003142A3 (cs) * | 2000-07-21 | 2003-06-18 | Smithkline Beecham Corporation | Kalcilytické sloučeniny |
FR2812875B1 (fr) | 2000-08-08 | 2003-12-12 | Centre Nat Rech Scient | Nouvelles diamines possedant une activite modulatrice des casr et leur mode de preparation |
DE60136187D1 (de) | 2000-08-11 | 2008-11-27 | Japan Tobacco Inc | Calciumrezeptor-antagonisten |
EP1383511B1 (fr) * | 2000-10-25 | 2006-10-25 | SmithKline Beecham Corporation | Composes calcilytiques |
US6476046B1 (en) | 2000-12-04 | 2002-11-05 | Sepracor, Inc. | Diazabicyclo[4.3.0]nonanes, and methods of use thereof |
MXPA04011472A (es) | 2002-05-22 | 2005-02-14 | Amgen Inc | Derivados de amino-piridina, piridina y piridazina para usarse como ligandos del receptor vaniloide para el tratamiento del dolor. |
WO2004014871A1 (fr) | 2002-08-08 | 2004-02-19 | Amgen Inc. | Ligands de recepteur vanilloide et leur utilisation dans des traitements |
TWI316511B (en) | 2002-11-26 | 2009-11-01 | Smithkline Beecham Corp | Calcilytic compounds |
US7105537B2 (en) | 2003-01-28 | 2006-09-12 | Bristol-Myers Squibb Company | 2-substituted cyclic amines as calcium sensing receptor modulators |
US7205322B2 (en) | 2003-02-12 | 2007-04-17 | Bristol-Myers Squibb Company | Thiazolidine compounds as calcium sensing receptor modulators |
NZ541188A (en) | 2003-04-23 | 2008-01-31 | Japan Tobacco Inc | calcium receptor antagonists |
JPWO2004106280A1 (ja) | 2003-05-28 | 2006-07-20 | 日本たばこ産業株式会社 | CaSRアンタゴニスト |
US7265145B2 (en) | 2003-05-28 | 2007-09-04 | Bristol-Myers Squibb Company | Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method |
US7534798B2 (en) | 2004-02-11 | 2009-05-19 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
MY139645A (en) | 2004-02-11 | 2009-10-30 | Amgen Inc | Vanilloid receptor ligands and their use in treatments |
WO2006089311A1 (fr) | 2005-02-15 | 2006-08-24 | Amgen Inc. | Ligands des recepteurs vanilloides et leurs utilisations therapeutiques |
WO2010103429A1 (fr) | 2009-03-10 | 2010-09-16 | Pfizer Inc. | Dérivés de l'acide 1,1-(diméthyl-éthylamino)-2-hydroxy-propoxy]-éthyl}-3-méthyl-biphényl-4-carboxylique utiles en tant qu'antagonistes des récepteurs du calcium |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL83966A (en) * | 1986-09-26 | 1992-03-29 | Schering Ag | Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them |
UY24949A1 (es) * | 1997-04-08 | 2001-04-30 | Smithkline Beecham Corp | Compuestos calcilíticos |
-
1999
- 1999-04-06 AR ARP990101555A patent/AR014975A1/es not_active Application Discontinuation
- 1999-04-08 CA CA002327188A patent/CA2327188A1/fr not_active Abandoned
- 1999-04-08 EP EP99917374A patent/EP1069901A4/fr not_active Withdrawn
- 1999-04-08 CO CO99020600A patent/CO5021223A1/es unknown
- 1999-04-08 JP JP2000542012A patent/JP2002510636A/ja not_active Withdrawn
- 1999-04-08 WO PCT/US1999/007760 patent/WO1999051241A1/fr not_active Application Discontinuation
- 1999-04-08 AU AU35513/99A patent/AU3551399A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1069901A4 (fr) | 2001-06-13 |
AR014975A1 (es) | 2001-04-11 |
CO5021223A1 (es) | 2001-03-27 |
WO1999051241A1 (fr) | 1999-10-14 |
AU3551399A (en) | 1999-10-25 |
JP2002510636A (ja) | 2002-04-09 |
EP1069901A1 (fr) | 2001-01-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2327188A1 (fr) | Composes calcilytiques et leur utilisation | |
US6335338B1 (en) | Calcilytic compounds | |
US6417215B1 (en) | Calcilytic compounds | |
EP1713767A1 (fr) | Composes calcilytiques | |
US6864267B2 (en) | Calcilytic compounds | |
AU764746B2 (en) | Calcilytic compounds | |
EP1368318B1 (fr) | Composes calcilytiques | |
US20040009980A1 (en) | Calcilytic compounds | |
AU2001276923A1 (en) | Calcilytic compounds | |
WO1998044925A1 (fr) | Composes calcilytiques | |
EP1383511B1 (fr) | Composes calcilytiques | |
WO2000009132A1 (fr) | Composes calcilytiques | |
US20020052509A1 (en) | Calcilytic compounds and method of use | |
WO2005030746A1 (fr) | Composes calcilytiques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |